author-photo

Carol M. Richman

University of California, Davis
University of Chicago

56

Papers

1573

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome.

2021 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
367: Reduced intensity stem cell transplant (RIST) as salvage treatment for relapse following myeloablative allogeneic transplantation in adult acute myeloid leukemia

2007 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (4)
Reduced Intensity Stem Cell Transplant (RIST) as Salvage Treatment for Relapse Following Myeloablative Allogeneic Transplantation in Adult Acute Myeloid Leukemia.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Intensive Care Unit Admissions in Patients with Hematologic Malignancies: Outcomes and Prognostic Indicators.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

2005 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (26)
Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry

2005 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (6)
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.

2005 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (69)
Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature

2004 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (14)
Combined modality radioimmunotherapy (RIT) in metastatic prostate (PC) and breast cancer (BC) using paclitaxel (PT) and a MUC-1 monoclonal antibody, m170, linked to yttrium-90 (Y-90): A phase I trial

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)